Publication | Open Access

Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines

Dose ReductionMedicinePharmacologyFolinic AcidHuman HeadPharmacotherapyHead And Neck CancerAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer Research